Author

Sonal Joshi

International Centre for Genetic Engineering and BiotechnologyORCID 0009-0003-3536-2028Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Federica BenvenutiiD· 3 shared Giulia Maria PipernoiD· 3 shared Lucía LópeziD· 3 shared Luciano Gastón MorosiiD· 3 shared Roberto AmadioiD· 3 shared Alberto BardelliiD· 1 shared Alessandra RustighiiD· 1 shared Camilla Volponi· 1 shared

Activity by Year

2024-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Federica BenvenutiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyOncoImmunologyPeer-reviewedJun 14, 2024

ALCAM-mediated synapses between DC1 and CD8 T cells are inhibited in advanced lung tumors

Luciano Gastón Morosi, Giulia Maria Piperno, Lucía López…·Federica Benvenuti

The paper shows that ALCAM-mediated synapses between DC1 and CD8 T cells decrease in advanced lung tumors, impairing immune responses.

13 citations

mouseproteomics

𝕏 PostBluesky

ImmunologyCell ReportsPeer-reviewedApr 1, 2024

Tim4 enables large peritoneal macrophages to cross-present tumor antigens at early stages of tumorigenesis

Sonal Joshi, Lucía López, Luciano Gastón Morosi…·Federica Benvenuti

This study shows TIM4 enables large peritoneal macrophages to cross-present tumor antigens early in tumorigenesis, promoting CD8 T cell activation and immune surveillance.

22 citations

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedMar 13, 2024

DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors

Lucía López, Luciano Gastón Morosi, Federica La Terza…·Federica Benvenuti

The paper shows that DC-based therapy enhances CD8 T cell responses to neoantigens in lung tumors, particularly in high TMB tumors.

56 citationstop 1%

mousebulk RNA-seq

𝕏 PostBluesky